NCT02559193

Pharmacogenetic Testing for Medication Management.

Medication Interactions to Detect Adverse Situations

• Status: Withdrawn
• Phase: —
• Study type: Observational
• Enrollment: 0 (actual)
• Sponsor: First Vitals LLC · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The Study is a single-arm prospective trial of patients receiving at least one medication with a known association between genetics and drug metabolism. All patients will undergo genetic testing as determined by their treating physician. The specific genes tested will, in general, be based upon the drugs the patients are taking or those that the patient's treating physician is considering as potential substitutes for current medications.

Detailed description

In this data collection only trial design, the PGx test is not a protocol-specified procedure. Rather, patients are eligible if they have undergone PGx testing within the last 90 days. Thus, PGx testing will not be performed solely for inclusion in this clinical research initiative.

Conditions

• Medication Management

Interventions

Type	Name	Description
OTHER	Observational study, data collection only trial.	Data collection only trial design.

Timeline

• Start date: 2016-01-01
• Primary completion: 2018-05-01
• Completion: 2018-05-01
• First posted: 2015-09-24
• Last updated: 2019-08-01